0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-15123
Home | Market Reports | Science| Biological Sciences
Global Single Nucleotide Polymorphism SNP Genotyping Market Size Status and Forecast 2022
BUY CHAPTERS

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-15123
Report
September 2022
129 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Single Nucleotide Polymorphism (SNP) Genotyping market is projected to reach US$ 65510 million by 2028 from an estimated US$ 20770 million in 2022, at a CAGR of 21.1% during 2023 and 2028.

Global Single Nucleotide Polymorphism (SNP) Genotyping key players include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, etc. Global top five players hold a share about 65%.
North America is the largest market, with a share about 40%, followed by Europe and Japan, having a total share about 35 percent.
In terms of product, the segment includes Transversion, Transition. And in terms of application, the largest application is Diagnostics, followed by Animal, Plant, Research, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Single Nucleotide Polymorphism (SNP) Genotyping, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Single Nucleotide Polymorphism (SNP) Genotyping.
The Single Nucleotide Polymorphism (SNP) Genotyping market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Single Nucleotide Polymorphism (SNP) Genotyping market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Nucleotide Polymorphism (SNP) Genotyping companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences
Product Type Insights
Global markets are presented by Single Nucleotide Polymorphism (SNP) Genotyping type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Single Nucleotide Polymorphism (SNP) Genotyping are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Type

Transversion
Transition
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Single Nucleotide Polymorphism (SNP) Genotyping market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Single Nucleotide Polymorphism (SNP) Genotyping market.

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Application

Diagnostics
Animal
Plant
Research
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Single Nucleotide Polymorphism (SNP) Genotyping market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single Nucleotide Polymorphism (SNP) Genotyping market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Single Nucleotide Polymorphism (SNP) Genotyping and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Single Nucleotide Polymorphism (SNP) Genotyping industry.
This report helps stakeholders to gain insights into which regions to target globally.
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single Nucleotide Polymorphism (SNP) Genotyping.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

1 Study Coverage
1.1 Single Nucleotide Polymorphism (SNP) Genotyping Product Introduction
1.2 Market by Type
1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Transversion
1.2.3 Transition
1.3 Market by Application
1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Diagnostics
1.3.3 Animal
1.3.4 Plant
1.3.5 Research
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Estimates and Forecasts
2.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region: 2022 Versus 2028
2.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region: 2017-2022
2.2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Forecast by Region (2023-2028)
2.2.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Region (2017-2028)
3 Global Single Nucleotide Polymorphism (SNP) Genotyping by Company
3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Company (2017-2022)
3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Single Nucleotide Polymorphism (SNP) Genotyping Companies around the World: Ranking by Revenue
3.3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Headquarters & Product Type
3.4.1 Single Nucleotide Polymorphism (SNP) Genotyping Companies Headquarters
3.4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Product & Service
3.4.3 Date of International Companies Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
3.5 Global Single Nucleotide Polymorphism (SNP) Genotyping Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Illumina
4.1.1 Illumina Corporation Information
4.1.2 Illumina Description, Business Overview
4.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.1.4 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.1.5 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.1.6 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.1.7 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.1.8 Illumina Recent Developments
4.2 Affymetrix
4.2.1 Affymetrix Corporation Information
4.2.2 Affymetrix Description, Business Overview
4.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.2.4 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.2.5 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.2.6 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.2.7 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.2.8 Affymetrix Recent Developments
4.3 Applied Biosystems
4.3.1 Applied Biosystems Corporation Information
4.3.2 Applied Biosystems Description, Business Overview
4.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.3.4 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.3.5 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.3.6 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.3.7 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.3.8 Applied Biosystems Recent Developments
4.4 Agilent Technologies
4.4.1 Agilent Technologies Corporation Information
4.4.2 Agilent Technologies Description, Business Overview
4.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.4.4 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.4.5 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.4.6 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.4.7 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.4.8 Agilent Technologies Recent Developments
4.5 Beckman Coulter
4.5.1 Beckman Coulter Corporation Information
4.5.2 Beckman Coulter Description, Business Overview
4.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.5.4 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.5.5 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.5.6 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.5.7 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.5.8 Beckman Coulter Recent Developments
4.6 Roche
4.6.1 Roche Corporation Information
4.6.2 Roche Description, Business Overview
4.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.6.4 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.6.5 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.6.6 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.6.7 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.6.8 Roche Recent Development
4.7 Qiagen
4.7.1 Qiagen Corporation Information
4.7.2 Qiagen Description, Business Overview
4.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.7.4 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.7.5 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.7.6 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.7.7 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.7.8 Qiagen Recent Development
4.8 Luminex Corporation
4.8.1 Luminex Corporation Corporation Information
4.8.2 Luminex Corporation Description, Business Overview
4.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.8.4 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.8.5 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.8.6 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.8.7 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.8.8 Luminex Corporation Recent Development
4.9 Enzo Life Sciences
4.9.1 Enzo Life Sciences Corporation Information
4.9.2 Enzo Life Sciences Description, Business Overview
4.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.9.4 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.9.5 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.9.6 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.9.7 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.9.8 Enzo Life Sciences Recent Development
4.10 Bio-rad
4.10.1 Bio-rad Corporation Information
4.10.2 Bio-rad Description, Business Overview
4.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.10.4 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.10.5 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.10.6 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.10.7 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.10.8 Bio-rad Recent Development
4.11 Sequenom
4.11.1 Sequenom Corporation Information
4.11.2 Sequenom Description, Business Overview
4.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.11.4 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.11.5 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.11.6 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.11.7 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.11.8 Sequenom Recent Development
4.12 Ocimum Biosolutions
4.12.1 Ocimum Biosolutions Corporation Information
4.12.2 Ocimum Biosolutions Description, Business Overview
4.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.12.4 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.12.5 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.12.6 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.12.7 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.12.8 Ocimum Biosolutions Recent Development
4.13 GE Healthcare
4.13.1 GE Healthcare Corporation Information
4.13.2 GE Healthcare Description, Business Overview
4.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.13.4 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.13.5 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.13.6 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.13.7 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.13.8 GE Healthcare Recent Development
4.14 GenScript
4.14.1 GenScript Corporation Information
4.14.2 GenScript Description, Business Overview
4.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.14.4 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.14.5 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.14.6 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.14.7 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.14.8 GenScript Recent Development
4.15 Douglas Scientific
4.15.1 Douglas Scientific Corporation Information
4.15.2 Douglas Scientific Description, Business Overview
4.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.15.4 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.15.5 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.15.6 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.15.7 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.15.8 Douglas Scientific Recent Development
4.16 BGI
4.16.1 BGI Corporation Information
4.16.2 BGI Description, Business Overview
4.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.16.4 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.16.5 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.16.6 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.16.7 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.16.8 BGI Recent Development
4.17 Beijing Sunbiotech
4.17.1 Beijing Sunbiotech Corporation Information
4.17.2 Beijing Sunbiotech Description, Business Overview
4.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.17.4 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.17.5 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.17.6 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.17.7 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.17.8 Beijing Sunbiotech Recent Development
4.18 HuaGene Biotech
4.18.1 HuaGene Biotech Corporation Information
4.18.2 HuaGene Biotech Description, Business Overview
4.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.18.4 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.18.5 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.18.6 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.18.7 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.18.8 HuaGene Biotech Recent Development
4.19 Generay Biotech
4.19.1 Generay Biotech Corporation Information
4.19.2 Generay Biotech Description, Business Overview
4.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.19.4 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.19.5 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.19.6 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.19.7 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.19.8 Generay Biotech Recent Development
4.20 Benegene
4.20.1 Benegene Corporation Information
4.20.2 Benegene Description, Business Overview
4.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.20.4 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.20.5 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.20.6 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.20.7 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.20.8 Benegene Recent Development
4.21 Shanghai Biochip
4.21.1 Shanghai Biochip Corporation Information
4.21.2 Shanghai Biochip Description, Business Overview
4.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.21.4 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.21.5 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.21.6 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.21.7 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.21.8 Shanghai Biochip Recent Development
4.22 GENESKY
4.22.1 GENESKY Corporation Information
4.22.2 GENESKY Description, Business Overview
4.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.22.4 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.22.5 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.22.6 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.22.7 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.22.8 GENESKY Recent Development
4.23 HD Biosciences
4.23.1 HD Biosciences Corporation Information
4.23.2 HD Biosciences Description, Business Overview
4.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Products Offered
4.23.4 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Gross Margin (2017-2022)
4.23.5 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Product in 2021
4.23.6 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application in 2021
4.23.7 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Geographic Area in 2021
4.23.8 HD Biosciences Recent Development
5 Breakdown Data by Type
5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022)
5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Forecast by Type (2023-2028)
5.3 Single Nucleotide Polymorphism (SNP) Genotyping Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022)
6.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Forecast by Application (2023-2028)
6.3 Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2017-2028
7.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Facts & Figures by Country (2017-2028)
7.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022)
7.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022)
8.4 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022)
9 Europe
9.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2017-2028
9.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Facts & Figures by Country (2017-2028)
9.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022)
9.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2017-2028
10.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Facts & Figures by Country (2017-2028)
10.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022)
10.4 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022)
11.4 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Single Nucleotide Polymorphism (SNP) Genotyping Supply Chain Analysis
12.2 Single Nucleotide Polymorphism (SNP) Genotyping Key Raw Materials and Upstream Suppliers
12.3 Single Nucleotide Polymorphism (SNP) Genotyping Clients Analysis
12.4 Single Nucleotide Polymorphism (SNP) Genotyping Sales Channel and Sales Model Analysis
12.4.1 Single Nucleotide Polymorphism (SNP) Genotyping Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Single Nucleotide Polymorphism (SNP) Genotyping Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Single Nucleotide Polymorphism (SNP) Genotyping Distributors
13 Market Dynamics
13.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends
13.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
13.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
13.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Companies of Transversion
    Table 3. Major Companies of Transition
    Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (US$ Million): 2022 VS 2028
    Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region (2017-2022) & (US$ Million)
    Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 8. Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Company (2017-2022) & (US$ Million)
    Table 9. Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Company (2017-2022)
    Table 10. Ranking of Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue (US$ Million) in 2021
    Table 11. Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 12. Global Single Nucleotide Polymorphism (SNP) Genotyping by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2021)
    Table 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Headquarters
    Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Companies Product & Service
    Table 15. Date of International Companies Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
    Table 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Mergers & Acquisitions, Expansion Plans
    Table 17. Illumina Corporation Information
    Table 18. Illumina Description and Business Overview
    Table 19. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 20. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 21. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 22. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 23. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 24. Illumina Recent Development
    Table 25. Affymetrix Corporation Information
    Table 26. Affymetrix Description and Business Overview
    Table 27. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 28. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 29. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 30. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 31. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 32. Affymetrix Recent Development
    Table 33. Applied Biosystems Corporation Information
    Table 34. Applied Biosystems Description and Business Overview
    Table 35. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 36. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 37. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 38. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 39. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 40. Applied Biosystems Recent Development
    Table 41. Agilent Technologies Corporation Information
    Table 42. Agilent Technologies Description and Business Overview
    Table 43. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 44. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 45. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 46. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 47. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 48. Agilent Technologies Recent Development
    Table 49. Beckman Coulter Corporation Information
    Table 50. Beckman Coulter Description and Business Overview
    Table 51. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 52. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 53. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 54. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 55. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 56. Beckman Coulter Recent Development
    Table 57. Roche Corporation Information
    Table 58. Roche Description and Business Overview
    Table 59. Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 60. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 61. Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 62. Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 63. Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 64. Qiagen Corporation Information
    Table 65. Qiagen Description and Business Overview
    Table 66. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 67. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 68. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 69. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 70. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 71. Luminex Corporation Corporation Information
    Table 72. Luminex Corporation Description and Business Overview
    Table 73. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 74. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 75. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 76. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 77. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 78. Enzo Life Sciences Corporation Information
    Table 79. Enzo Life Sciences Description and Business Overview
    Table 80. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 81. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 82. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 83. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 84. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 85. Bio-rad Corporation Information
    Table 86. Bio-rad Description and Business Overview
    Table 87. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 88. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 89. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 90. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 91. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 92. Sequenom Corporation Information
    Table 93. Sequenom Description and Business Overview
    Table 94. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 95. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 96. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 97. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 98. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 99. Ocimum Biosolutions Corporation Information
    Table 100. Ocimum Biosolutions Description and Business Overview
    Table 101. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 102. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 103. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 104. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 105. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 106. GE Healthcare Corporation Information
    Table 107. GE Healthcare Description and Business Overview
    Table 108. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 109. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 110. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 111. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 112. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 113. GenScript Corporation Information
    Table 114. GenScript Description and Business Overview
    Table 115. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 116. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 117. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 118. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 119. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 120. Douglas Scientific Corporation Information
    Table 121. Douglas Scientific Description and Business Overview
    Table 122. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 123. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 124. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 125. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 126. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 127. BGI Corporation Information
    Table 128. BGI Description and Business Overview
    Table 129. BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 130. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 131. BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 132. BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 133. BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 134. Beijing Sunbiotech Corporation Information
    Table 135. Beijing Sunbiotech Description and Business Overview
    Table 136. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 137. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 138. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 139. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 140. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 141. HuaGene Biotech Corporation Information
    Table 142. HuaGene Biotech Description and Business Overview
    Table 143. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 144. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 145. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 146. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 147. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 148. Generay Biotech Corporation Information
    Table 149. Generay Biotech Description and Business Overview
    Table 150. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 151. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 152. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 153. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 154. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 155. Benegene Corporation Information
    Table 156. Benegene Description and Business Overview
    Table 157. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 158. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 159. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 160. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 161. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 162. Shanghai Biochip Corporation Information
    Table 163. Shanghai Biochip Description and Business Overview
    Table 164. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 165. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 166. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 167. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 168. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 169. GENESKY Corporation Information
    Table 170. GENESKY Description and Business Overview
    Table 171. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 172. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 173. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 174. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 175. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 176. HD Biosciences Corporation Information
    Table 177. HD Biosciences Description and Business Overview
    Table 178. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 179. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product
    Table 180. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Product in 2021
    Table 181. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Application in 2021
    Table 182. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue Proportion of Single Nucleotide Polymorphism (SNP) Genotyping by Geographic Area in 2021
    Table 183. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022) & (US$ Million)
    Table 184. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022) & (US$ Million)
    Table 185. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 186. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2017-2022) & (US$ Million)
    Table 187. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2023-2028) & (US$ Million)
    Table 188. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022) & (US$ Million)
    Table 189. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022) & (US$ Million)
    Table 190. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region (2017-2028) & (US$ Million)
    Table 191. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Region (2023-2028) & (US$ Million)
    Table 192. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022) & (US$ Million)
    Table 193. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022) & (US$ Million)
    Table 194. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2017-2022) & (US$ Million)
    Table 195. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2023-2028) & (US$ Million)
    Table 196. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022) & (US$ Million)
    Table 197. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022) & (US$ Million)
    Table 198. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2017-2022) & (US$ Million)
    Table 199. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2023-2028) & (US$ Million)
    Table 200. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022) & (US$ Million)
    Table 201. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022) & (US$ Million)
    Table 202. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2017-2022) & (US$ Million)
    Table 203. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Country (2023-2028) & (US$ Million)
    Table 204. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Type (2017-2022) & (US$ Million)
    Table 205. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Application (2017-2022) & (US$ Million)
    Table 206. Single Nucleotide Polymorphism (SNP) Genotyping Key Raw Materials, Industry Status and Trend
    Table 207. Single Nucleotide Polymorphism (SNP) Genotyping Key Raw Materials and Upstream Suppliers
    Table 208. Single Nucleotide Polymorphism (SNP) Genotyping Clients Status and Trend
    Table 209. Single Nucleotide Polymorphism (SNP) Genotyping Typical Clients
    Table 210. Single Nucleotide Polymorphism (SNP) Genotyping Distributors
    Table 211. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends
    Table 212. Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
    Table 213. Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
    Table 214. Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
    Table 215. Research Programs/Design for This Report
    Table 216. Key Data Information from Secondary Sources
    Table 217. Key Data Information from Primary Sources
List of Figures
    Figure 1. Single Nucleotide Polymorphism (SNP) Genotyping Product Picture
    Figure 2. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type in 2021 & 2028
    Figure 3. Transversion Product Picture
    Figure 4. Transition Product Picture
    Figure 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application in 2021 & 2028
    Figure 6. Diagnostics
    Figure 7. Animal
    Figure 8. Plant
    Figure 9. Research
    Figure 10. Others
    Figure 11. Single Nucleotide Polymorphism (SNP) Genotyping Report Years Considered
    Figure 12. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size 2017-2028 (US$ Million)
    Figure 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Region: 2022 Versus 2028
    Figure 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Region (2017-2028)
    Figure 16. Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share Forecast by Type (2017-2028)
    Figure 18. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share Forecast by Application (2017-2028)
    Figure 19. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue 2017-2028 (US$ Million)
    Figure 20. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2017-2022)
    Figure 21. North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2017-2022)
    Figure 22. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue 2017-2028 (US$ Million)
    Figure 23. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Region (2017-2028)
    Figure 24. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2017-2022)
    Figure 25. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2017-2022)
    Figure 26. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 27. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Country (2017-2028)
    Figure 28. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2017-2022)
    Figure 29. Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2017-2022)
    Figure 30. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 31. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Country (2017-2022)
    Figure 32. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2017-2022)
    Figure 33. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2017-2022)
    Figure 34. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 35. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Country (2017-2028)
    Figure 36. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2017-2022)
    Figure 37. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2017-2022)
    Figure 38. Single Nucleotide Polymorphism (SNP) Genotyping Supply Chain (Upstream and Downstream Market)
    Figure 39. Global Production Market Share of Single Nucleotide Polymorphism (SNP) Genotyping Raw Materials by Region in 2021
    Figure 40. Single Nucleotide Polymorphism (SNP) Genotyping Distribution Channels
    Figure 41. Global Single Nucleotide Polymorphism (SNP) Genotyping Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 42. Global Single Nucleotide Polymorphism (SNP) Genotyping Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 43. Bottom-up and Top-down Approaches for This Report
    Figure 44. Data Triangulation
    Figure 45. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Insect Cell Culture Medium Market Research Report 2022
Global Insect Cell Culture Medium Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-35A11450
Thu Nov 03 00:00:00 UTC 2022

Add to Cart

Global CAR T Cell Therapy Market Insights and Forecast to 2028
Global CAR T-Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-11J6103
Thu Oct 27 00:00:00 UTC 2022

Add to Cart

Global SNP Genotyping and Analysis Market Insights and Forecast to 2028
Global SNP Genotyping and Analysis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-31M6639
Mon Oct 24 00:00:00 UTC 2022

Add to Cart

Global Exome Sequencing Market Insights and Forecast to 2028
Global Exome Sequencing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-4W8968
Sun Oct 23 00:00:00 UTC 2022

Add to Cart